195 related articles for article (PubMed ID: 334437)
21. Drug metabolism and liver disease: a drug-gene-environment interaction.
Zgheib NK; Branch RA
Drug Metab Rev; 2017 Feb; 49(1):35-55. PubMed ID: 27957864
[TBL] [Abstract][Full Text] [Related]
22. [Effects of liver disease on drug pharmacokinetics].
Su CY
Sheng Li Ke Xue Jin Zhan; 1983 Jul; 14(3):238-42. PubMed ID: 6648457
[No Abstract] [Full Text] [Related]
23. [Changes in drug kinetics in liver diseases and their importance in rational pharmacotherapy].
Danysz A
Pol Tyg Lek; 1977 Dec; 32(52):2057-60. PubMed ID: 604977
[No Abstract] [Full Text] [Related]
24. Altered drug metabolism and elevated serum bile acids in liver disease: a unified pharmacokinetic explanation.
Gilmore IT; Hofmann AF
Gastroenterology; 1980 Jan; 78(1):177-9. PubMed ID: 7350025
[No Abstract] [Full Text] [Related]
25. Clinical pharmacokinetics of beta-adrenoceptor blocking drugs in thyroid disease.
Feely J
Clin Pharmacokinet; 1983; 8(1):1-16. PubMed ID: 6132696
[No Abstract] [Full Text] [Related]
26. Protein binding and kinetics of drugs in liver diseases.
Blaschke TF
Clin Pharmacokinet; 1977; 2(1):32-44. PubMed ID: 322909
[TBL] [Abstract][Full Text] [Related]
27. Drug pharmacokinetics in cardiac and hepatic disease.
Williams RL; Benet LZ
Annu Rev Pharmacol Toxicol; 1980; 20():389-413. PubMed ID: 6992701
[No Abstract] [Full Text] [Related]
28. Pharmacokinetics in the 1980s.
Balant LP
Clin Ther; 1984; 6(2):112-24. PubMed ID: 6705009
[TBL] [Abstract][Full Text] [Related]
29. Circadian changes of drug disposition in man.
Reinberg A; Smolensky MH
Clin Pharmacokinet; 1982; 7(5):401-20. PubMed ID: 6754207
[TBL] [Abstract][Full Text] [Related]
30. The influence of host factors on drug response. VII. Renal diseases.
Vesell ES
Ration Drug Ther; 1981 Nov; 15(11):1-9. PubMed ID: 7345476
[No Abstract] [Full Text] [Related]
31. Genetic and environmental factors affecting host response to drugs and other chemical compounds in our environment.
Vesell ES; Passananti GT
Environ Health Perspect; 1977 Oct; 20():159-82. PubMed ID: 598349
[TBL] [Abstract][Full Text] [Related]
32. Editorial: The significance and determinants of drug metabolism in man.
Stevenson IH
Digestion; 1973; 8(1):80-6. PubMed ID: 4776491
[No Abstract] [Full Text] [Related]
33. [Drug therapy and liver diseases].
Pentikäinen PJ
Duodecim; 1980; 96(5):383-93. PubMed ID: 7449683
[No Abstract] [Full Text] [Related]
34. [Characteristics of drug therapy in kidney and liver insufficiency, in infancy and old age, during pregnancy and lactation].
Rameis H
Wien Med Wochenschr; 1983 Mar; 133(6):141-51. PubMed ID: 6858179
[No Abstract] [Full Text] [Related]
35. Hepatic first-pass metabolism in liver disease.
Blaschke TF; Rubin PC
Clin Pharmacokinet; 1979; 4(6):423-32. PubMed ID: 391462
[No Abstract] [Full Text] [Related]
36. [Disorders of pharmacokinetics in pathological states and their clinical significance].
Orzechowska-Juzwenko K; Bolanowski M; Janicki AG
Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1681-6. PubMed ID: 6522322
[No Abstract] [Full Text] [Related]
37. Drug metabolism in patients with liver disease.
Secor JW; Schenker S
Adv Intern Med; 1987; 32():379-405. PubMed ID: 3548257
[No Abstract] [Full Text] [Related]
38. Influence of age and smoking on drug kinetics in man: studies using model compounds.
Vestal RE; Wood AJ
Clin Pharmacokinet; 1980; 5(4):309-19. PubMed ID: 6994978
[TBL] [Abstract][Full Text] [Related]
39. Vitamin status in metabolic upsets.
Baker H; Frank O
World Rev Nutr Diet; 1968; 9():124-60. PubMed ID: 4885078
[No Abstract] [Full Text] [Related]
40. Drugs and the liver.
Reidenberg MM; Breckenridge A
Clin Pharmacol Ther; 1998 Oct; 64(4):353-4. PubMed ID: 9797790
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
